Rodman & Renshaw Re-Initiates Coverage on DUSA Pharmaceuticals (DUSA) with a Market Outperform, Sees as Possible Takeover Target

October 7, 2008 7:49 AM EDT Send to a Friend
Rodman & Renshaw re-initiates coverage on DUSA Pharmaceuticals (Nasdaq: DUSA) with a Market Outperform. Price target $6.

Rodman ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login